Recombinant Mycobacterium ulcerans Elongation factor Ts (tsf)

Shipped with Ice Packs
In Stock

Description

Definition and Biological Role

Elongation Factor Ts (EF-Ts) is a guanine nucleotide exchange factor (GEF) that catalyzes the regeneration of active EF-Tu·GTP complexes from inactive EF-Tu·GDP during bacterial protein synthesis. In M. ulcerans, EF-Ts ensures efficient tRNA delivery to the ribosome by recycling EF-Tu, a process vital for translation . The recombinant form is produced heterologously (e.g., in E. coli) for functional and immunological studies .

Recombinant Production and Purification

Recombinant M. ulcerans tsf is expressed in heterologous systems (e.g., E. coli) using plasmid vectors (Table 1).

Table 1: Recombinant M. ulcerans EF-Ts Production Overview4

ParameterDetails
Expression systemE. coli, yeast, baculovirus, or mammalian cells
TagN-terminal hexahistidine (His6)
Purity>95% (verified via SDS-PAGE)
StorageLyophilized or liquid form at -80°C
ApplicationsVaccine development, enzymatic assays, structural studies

Functional Assays and Mechanistic Insights

Recombinant EF-Ts accelerates ternary complex (EF-Tu·GTP·aa-tRNA) formation and dissociation rates by 10–100-fold, as shown in kinetic assays .

Table 2: Key Functional Findings5

ProcessEF-Ts Role
Ternary complex formationReduces EF-Tu’s affinity for GDP, enabling rapid GTP binding.
Ternary complex decayDestabilizes EF-Tu·GTP·aa-tRNA in the presence of non-hydrolyzable GTP analogs.
Nucleotide exchangeCatalyzes EF-Tu·GDP → EF-Tu·GTP conversion via conformational remodeling.

Applications in Research and Therapeutics

  1. Vaccine Development:

    • Recombinant EF-Ts is used as an antigen in subunit vaccines to elicit immune responses against M. ulcerans .

    • In murine models, recombinant BCG expressing M. ulcerans antigens (e.g., Ag85A) enhances Th1-driven IFNγ production, suggesting EF-Ts could similarly boost protective immunity .

  2. Antibiotic Target Validation:

    • EF-Ts’s role in translation makes it a potential target for novel antibiotics, though no direct inhibitors are yet reported .

Challenges and Future Directions

  • Structural Resolution: No crystal structures of M. ulcerans EF-Ts are available; homology modeling using E. coli (PDB: 1EFU) or T. thermophilus (PDB: 1DG1) templates is required .

  • Drug Discovery: High-throughput screening of EF-Ts inhibitors could address M. ulcerans’s intrinsic antibiotic resistance .

Product Specs

Form
Lyophilized powder. We will ship the in-stock format by default. If you have special format requirements, please note them when ordering.
Lead Time
Delivery times vary by purchase method and location. Contact your local distributor for specific delivery times. All proteins are shipped with blue ice packs by default. For dry ice shipping, contact us in advance; extra fees apply.
Notes
Avoid repeated freezing and thawing. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening to collect contents at the bottom. Reconstitute protein in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer ingredients, storage temperature, and protein stability. Liquid form shelf life is generally 6 months at -20°C/-80°C. Lyophilized form shelf life is generally 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
tsf; MUL_2068Elongation factor Ts; EF-Ts
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-271
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Mycobacterium ulcerans (strain Agy99)
Target Names
tsf
Target Protein Sequence
MANFTAADVK RLRELTGAGM LACKNALAES DGDFDKAVEA LRIKGAKDVG KRAERATAEG LVAAKDGALI ELNCETDFVA KNAEFQKLAD DIVAAAVASK AADVDALKAA SIGGQTVEEA IGALSAKIGE KLELRRVAIF GGTVETYLHR RAADLPPAVG VLVEYTGAGA EAAHAVALQI AALKARYLSR EDVPEDLVAS ERRIAEETAK EEGKPEQALP KIVEGRLNGF FKDAVLLEQP SVSDSKKSVK ALLDDAGVTV TQFVRFEVGQ A
Uniprot No.

Target Background

Function
Associates with the EF-Tu.GDP complex and promotes GDP to GTP exchange. Remains bound to the aminoacyl-tRNA.EF-Tu.GTP complex until GTP hydrolysis on the ribosome.
Database Links

KEGG: mul:MUL_2068

Protein Families
EF-Ts family
Subcellular Location
Cytoplasm.

Q&A

What is the role of Elongation Factor Ts in M. ulcerans protein synthesis?

Elongation Factor Ts (EF-Ts) in M. ulcerans functions as a nucleotide exchange factor that directly facilitates both the formation and disassociation of the EF-Tu·GTP·aa-tRNA ternary complex, which is essential for protein synthesis. This process involves EF-Ts catalyzing the release of GDP from EF-Tu after GTP hydrolysis and facilitating the binding of a new GTP molecule to regenerate active EF-Tu, enabling it to participate in subsequent rounds of translation elongation. The efficiency of this process is particularly significant in M. ulcerans due to its exceptionally slow growth rate (doubling time of 3.5 days), where optimal protein synthesis machinery is critical for bacterial viability .

Unlike most bacterial species, Mycobacterium EF-Ts likely plays a specialized role in adapting protein synthesis rates to changing environmental conditions, potentially including host environments, which could influence virulence factor production including mycolactone toxin synthesis regulation .

How is the tsf gene organized in the M. ulcerans genome?

The tsf gene in M. ulcerans is structured similarly to other mycobacterial species, though with specific adaptations reflecting its evolutionary trajectory from M. marinum. Typically, in mycobacteria, the tsf gene is located in a conserved genomic region that contains other translation-related genes.

The genomic context of tsf in M. ulcerans demonstrates the following characteristics:

FeatureDescription
Genome positionWithin conserved translation-related gene cluster
Upstream genesTypically includes rpsB (ribosomal protein S2)
Gene lengthApproximately 831 nucleotides (277 amino acids)
GC contentHigh (≈65%), consistent with mycobacterial genome bias
Regulatory elementsPromoters likely responsive to growth conditions

The conservation of this genomic organization across mycobacterial species suggests functional importance, while any M. ulcerans-specific variations might contribute to its unique growth properties and environmental adaptations .

What expression systems are optimal for recombinant M. ulcerans EF-Ts production?

When expressing recombinant M. ulcerans EF-Ts, researchers should consider the following expression systems, each with distinct advantages for mycobacterial protein production:

Expression SystemAdvantagesDisadvantagesOptimization Strategies
E. coli BL21(DE3)High yield, rapid growth, extensive genetic toolsCodon bias issues, potential inclusion body formationCodon optimization, lower induction temperature (16-20°C), co-expression with chaperones
M. smegmatisNative mycobacterial folding machinery, post-translational modificationsSlower growth, more complex manipulationUse of inducible promoters, optimization of growth media
Cell-free systemsAvoids toxicity issues, rapid productionHigher cost, technical complexitySupplementation with molecular chaperones, optimization of redox conditions

Most successful expressions utilize pET vectors with N-terminal His6-tags in E. coli systems, as demonstrated with similar mycobacterial elongation factors. When expressing M. ulcerans proteins specifically, researchers should account for the bacterium's adaptation to specific carbohydrates by supplementing expression media with glucose polymers, which have been shown to influence M. ulcerans metabolism .

What purification challenges are specific to M. ulcerans EF-Ts and how can they be addressed?

Purifying recombinant M. ulcerans EF-Ts presents several challenges due to mycobacterial protein characteristics. A systematic approach to addressing these challenges includes:

  • Solubility enhancement: M. ulcerans proteins often have hydrophobic regions that can cause aggregation. Using solubility-enhancing fusion partners (SUMO, MBP, TrxA) significantly improves yields of soluble protein.

  • Optimized lysis buffers: Incorporate components that maintain protein stability:

    • 50 mM Tris-HCl (pH 8.0)

    • 300 mM NaCl

    • 10% glycerol

    • 1 mM DTT

    • Protease inhibitor cocktail

    • 0.5% Triton X-100 (to help solubilize membrane-associated fractions)

  • Multi-step purification strategy:

    • Immobilized metal affinity chromatography (IMAC) using Ni-NTA for His-tagged proteins

    • Ion exchange chromatography to remove nucleic acid contamination

    • Size exclusion chromatography for final polishing and buffer exchange

  • Stability assessment: Use differential scanning fluorimetry to identify buffer conditions that maximize protein stability during storage. Many mycobacterial proteins benefit from the presence of glycerol (10-20%) and reducing agents during storage .

What assays can accurately measure M. ulcerans EF-Ts activity?

Multiple complementary approaches can be employed to characterize M. ulcerans EF-Ts activity comprehensively:

  • Nucleotide exchange assays:

    • Measure the rate of mantGDP dissociation from EF-Tu in the presence and absence of EF-Ts using fluorescence spectroscopy

    • Quantify the acceleration of GDP/GTP exchange rates on EF-Tu

    • Typical values for mycobacterial EF-Ts show 10-50 fold acceleration of exchange rates

  • Ternary complex formation kinetics:

    • Monitor the formation of EF-Tu·GTP·aa-tRNA using fluorescence anisotropy

    • Compare rates with and without EF-Ts to determine catalytic efficiency

    • Stopped-flow techniques provide high temporal resolution for fast kinetics

  • In vitro translation assays:

    • Reconstituted translation systems supplemented with varying concentrations of EF-Ts

    • Measure the rate of polypeptide synthesis using labeled amino acids

    • Assess the impact of environmental factors (pH, temperature, ion concentrations) that may be relevant to M. ulcerans environmental persistence

  • Protein-protein interaction analysis:

    • Surface plasmon resonance to determine binding kinetics between EF-Ts and EF-Tu

    • Isothermal titration calorimetry for thermodynamic parameters of the interaction

    • Pull-down assays to identify potential additional interaction partners in M. ulcerans lysates

These assays should be performed under conditions that mimic the natural growth environment of M. ulcerans, potentially including carbohydrate supplements known to influence its metabolism .

How does M. ulcerans EF-Ts function relate to mycolactone production?

While direct evidence linking EF-Ts to mycolactone production is limited, several important connections can be hypothesized and experimentally investigated:

  • Metabolic coordination: Under specific carbohydrate-rich conditions that downregulate mycolactone production, protein synthesis pathways including EF-Ts-mediated translation may be redirected toward alternative metabolic activities such as siderophore production. This metabolic shift suggests a potential regulatory network where translation factors like EF-Ts contribute to resource allocation between virulence factor production and other cellular processes .

  • Translational regulation: Mycolactone synthesis involves giant polyketide synthases encoded on a virulence plasmid. While research indicates that mycolactone regulation is not primarily at the transcriptional or translational level, the efficiency of translation (mediated by EF-Ts and other factors) could influence the cellular capacity for producing these complex enzymes .

  • Environmental adaptation: M. ulcerans adjusts mycolactone production based on environmental conditions, including its transition to intramacrophage growth where toxin production appears to be downregulated. This adaptation likely involves coordinated changes in protein synthesis patterns that would involve EF-Ts activity .

Environmental ConditionMycolactone ProductionHypothesized EF-Ts ActivityPotential Mechanism
Standard growth mediumNormalBaselineStandard protein synthesis
Carbohydrate enrichmentDecreasedPotentially alteredShift toward iron acquisition pathways
Intramacrophage growthDownregulatedPotentially specializedAdaptation to intracellular lifestyle
Iron limitationAssociated with increased mycobactinMay be upregulatedSupporting stress response proteins

Research approaches to investigate these connections could include comparative proteomics of M. ulcerans under conditions that alter mycolactone production, coupled with targeted studies of translation efficiency .

How might targeting M. ulcerans EF-Ts contribute to Buruli ulcer treatment strategies?

Targeting M. ulcerans EF-Ts represents a promising avenue for developing novel therapeutic approaches for Buruli ulcer, which currently lacks effective medical treatments beyond surgery. Strategic approaches include:

  • Selective inhibition: The structural differences between bacterial and eukaryotic elongation factors provide potential for designing selective inhibitors that target M. ulcerans EF-Ts without affecting host translation. Structure-based drug design approaches could identify compounds that specifically disrupt the EF-Ts:EF-Tu interaction surface unique to mycobacteria .

  • Growth inhibition: M. ulcerans' extremely slow growth rate (3.5 days doubling time) makes it particularly vulnerable to translation inhibition. Even moderate reduction in EF-Ts activity could significantly impair bacterial replication, potentially allowing host immune mechanisms to more effectively clear the infection .

  • Virulence attenuation: By targeting EF-Ts, it may be possible to alter the balance of protein synthesis in M. ulcerans, potentially reducing mycolactone production. Since this toxin is responsible for the extensive tissue necrosis and local immunosuppression characteristic of Buruli ulcer, reducing its production could mitigate disease severity even if bacterial clearance is not complete .

  • Combination therapy approaches: EF-Ts inhibitors could potentially enhance the effectiveness of existing antibiotics by compromising the bacterium's ability to synthesize proteins necessary for antibiotic resistance or stress responses. This approach might be particularly effective during the intramacrophage growth phase of M. ulcerans .

What role might M. ulcerans EF-Ts play in the bacterium's immune evasion strategies?

M. ulcerans EF-Ts likely contributes to immune evasion mechanisms through its support of the translation machinery required for bacterial adaptation within host environments:

  • Supporting mycolactone synthesis: While mycolactone regulation occurs primarily at post-translational levels, efficient translation machinery is necessary for producing the enzymatic machinery that synthesizes this immunosuppressive toxin. Mycolactone has been shown to inhibit multiple immune functions, including:

    • 95% inhibition of LPS-induced TNF and IL-10 release from human monocytes

    • Blocked production of IL-2 from activated T lymphocytes

    • Abrogation of TNF-induced NF-κB activation

    • Causing loss of monocyte adherence without cell death

  • Adaptation during host transitional phases: During the transition from extracellular to intramacrophage growth, M. ulcerans appears to modulate mycolactone production. This adaptation requires rapid reprogramming of protein synthesis, which would necessarily involve translation factors like EF-Ts .

  • Stress response during immune challenge: When faced with host immune pressures, bacteria typically upregulate stress response proteins. The efficiency of this response depends on translation factors including EF-Ts, especially in slow-growing organisms like M. ulcerans where rapid protein synthesis may be required despite generally slow metabolism .

Experimental approaches to investigate these connections could include creating conditional EF-Ts mutants and assessing their ability to produce mycolactone and survive within macrophages or animal models .

How does M. ulcerans EF-Ts function in the context of bacterial translocation?

Recent experimental models have revealed that M. ulcerans can translocate through the digestive tract in mammals, challenging previous understanding of its transmission and infection mechanisms. This finding has important implications for EF-Ts function:

  • Adaptation to digestive conditions: M. ulcerans must adapt to the harsh environments of the digestive tract, including acid exposure, bile salts, and nutrient fluctuations. Translation factors like EF-Ts likely play crucial roles in reprogramming protein synthesis during this stress response .

  • Systemic dissemination pathway: Experimental evidence shows M. ulcerans can be detected in the lymphatic system including cervical and axillary lymph nodes and the spleen following digestive tract exposure. This suggests that EF-Ts supports protein synthesis during a complex life cycle involving multiple host environments .

  • Mycolactone regulation during translocation: The absence of systemic mycolactone detection despite bacterial dissemination suggests that toxin production may be locally regulated. This points to sophisticated translational control mechanisms potentially involving EF-Ts that allow M. ulcerans to modulate virulence factor production based on its anatomical location .

Anatomical LocationM. ulcerans DetectionMycolactone StatusPotential EF-Ts Role
Digestive tractPositive for up to 10 daysLikely suppressedSupporting stress response proteins
Lymph nodes (cervical, axillary)PositiveNot systemically detectedEnabling adaptation to lymphatic environment
SpleenPositiveNot systemically detectedSupporting systemic dissemination
Skin/subcutaneous tissueNot detected in healthy or breached skinLocally produced in clinical infectionDifferent translational program in classic infection sites

These findings suggest that M. ulcerans EF-Ts may support distinct translational programs during different phases of infection and dissemination, representing a key area for future research .

What experimental approaches can identify novel interactions between M. ulcerans EF-Ts and other cellular components?

Advanced experimental strategies to uncover the extended interaction network of M. ulcerans EF-Ts include:

  • Proximity-dependent biotinylation (BioID): By fusing EF-Ts to a biotin ligase, researchers can identify proteins that come into close proximity with EF-Ts in living mycobacteria. This approach could reveal unexpected interactions beyond the canonical EF-Tu binding partner, potentially uncovering M. ulcerans-specific regulatory mechanisms.

  • Quantitative interactomics: Combining pull-down assays with mass spectrometry under various growth conditions (standard media, carbohydrate supplementation, iron limitation) could reveal condition-specific interaction partners that might link translation to mycolactone regulation .

  • Cryo-electron microscopy: Structural determination of M. ulcerans EF-Ts in complex with ribosomes and other translation factors could reveal unique features that contribute to this slow-growing pathogen's protein synthesis regulation.

  • Conditional depletion studies: Creating strains with regulatable EF-Ts expression would allow researchers to observe the consequences of reduced EF-Ts activity on various cellular processes, including:

    • Growth rate in different media compositions

    • Mycolactone production profiles

    • Siderophore synthesis

    • Response to environmental stresses

  • Comparative systems biology: Integrating transcriptomic, proteomic, and metabolomic data from M. ulcerans under different growth conditions, with focus on translation efficiency metrics, could reveal how EF-Ts activity coordinates with broader cellular responses to environmental changes .

These approaches would significantly advance understanding of how M. ulcerans adapts its protein synthesis machinery to support its unique lifestyle as a slow-growing environmental pathogen capable of producing a potent immunosuppressive toxin.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.